NeuroCytonix Launches Clinical Trial Studying Its NeuroCytotron Protocol for Autism
The NeuroCytotron utilizes non-invasive, safe tissue engineering technology to stimulate proteins that aid in the regeneration of brain cells. ROCKVILLE, MARYLAND, UNITED STATES, July 9, 2024 /EINPresswire.com/ -- NeuroCytonix, Inc., today …